The stability of the uterine estrogen receptor when complexed with estrogens or antiestrogens

Research output: Contribution to journalArticle

Abstract

As probes for possible conformational differences in estrogen receptor complexes when liganded with estrogen agonists or estrogen antagonists (antiestrogens), we have examined ligand-mediated thermal stability and resistance to trypsin-mediated proteolysis of uterine receptors occupied by a variety of steroidal and nonsteroidal estrogens and antiestrogens displaying a wide range of binding affinities for receptor. The estrogens examined (with chemical names and relative binding affinities in parentheses) were diethylstilbestrol (α,α'-diethyl-4,4'-stilbenediol (126%)), estradiol-17β (estra-1,3,5(10)-triene-3,17β-diol (100%)), 11β-methoxy-17-α-ethynylestradiol, R2858 (11β-methoxy-17α-ethynyl-estra-1,3,5(10)triene-3,17β-diol (65%)), zearalanol, P-1496 (6-(6,10-dihydroxyundecyl)-β-resorcylic acid μ-lactone (14%)), estriol (estra-1,3,5(10)-triene-3,16α,17β-triol (19%)), estrone (3-hydroxy-estra-1,3,5(10)-triene-17-one (15%)), and estradiol-17α (estra-1,3,5(10)-triene-3,17α-diol (5%)); the antiestrogens examined were CI-628 demethylated (α-[4-pyrrolidinoethoxy]phenyl4-hydroxy-α'-nitrostilbene (70%)), CI-628 (α-[4-pyrrolidinoethoxy]-phenyl-4-methoxy-α'-nitrostilbene (5%)), 11α-methoxyethynylestradiol, RU16117 (11α-methoxy-17α-ethynylestra-1,3,5(10)-triene-3,17β-diol (4%)), tamoxifen (trans-1 (p-dimethylaminoethoxyphenyl)-1,2-diphenyl-1-butene (5%)), and U23,469 ((±)-cis-3-[p-(1,2,3,4-tetrahydro-6-methoxy-2-phenyl-1-naphthyl)phenoxy]-1,2-propanediol (0.3%)). Ligand-mediated thermal stability and resistance to tryptic proteolysis were observed to be closely related to binding affinity for receptor and not to whether the ligand was an agonist or antagonist. Consequently, while the receptor may distinguish an agonist from an antagonist by some resulting conformational perturbation that is ultimately translated into different biological responses, this change is not manifested in any characteristic fashion by ligand-mediated thermal stability or protection against tryptic proteolysis.

Original languageEnglish (US)
Pages (from-to)406-412
Number of pages7
JournalMolecular Pharmacology
Volume18
Issue number3
StatePublished - 1980

Fingerprint

Zeranol
Estrogen Receptor Modulators
Estrogen Receptors
Nitromifene
Estrogens
Proteolysis
Ligands
Hot Temperature
moxestrol
Estradiol
Non-Steroidal Estrogens
Estrogen Antagonists
Estriol
Diethylstilbestrol
Estrone
Tamoxifen
Trypsin
Names

ASJC Scopus subject areas

  • Pharmacology

Cite this

The stability of the uterine estrogen receptor when complexed with estrogens or antiestrogens. / Pavlik, E. J.; Katzenellenbogen, Benita S.

In: Molecular Pharmacology, Vol. 18, No. 3, 1980, p. 406-412.

Research output: Contribution to journalArticle

@article{c7e4cef4dc5845b98df3bb6d9fa2e066,
title = "The stability of the uterine estrogen receptor when complexed with estrogens or antiestrogens",
abstract = "As probes for possible conformational differences in estrogen receptor complexes when liganded with estrogen agonists or estrogen antagonists (antiestrogens), we have examined ligand-mediated thermal stability and resistance to trypsin-mediated proteolysis of uterine receptors occupied by a variety of steroidal and nonsteroidal estrogens and antiestrogens displaying a wide range of binding affinities for receptor. The estrogens examined (with chemical names and relative binding affinities in parentheses) were diethylstilbestrol (α,α'-diethyl-4,4'-stilbenediol (126{\%})), estradiol-17β (estra-1,3,5(10)-triene-3,17β-diol (100{\%})), 11β-methoxy-17-α-ethynylestradiol, R2858 (11β-methoxy-17α-ethynyl-estra-1,3,5(10)triene-3,17β-diol (65{\%})), zearalanol, P-1496 (6-(6,10-dihydroxyundecyl)-β-resorcylic acid μ-lactone (14{\%})), estriol (estra-1,3,5(10)-triene-3,16α,17β-triol (19{\%})), estrone (3-hydroxy-estra-1,3,5(10)-triene-17-one (15{\%})), and estradiol-17α (estra-1,3,5(10)-triene-3,17α-diol (5{\%})); the antiestrogens examined were CI-628 demethylated (α-[4-pyrrolidinoethoxy]phenyl4-hydroxy-α'-nitrostilbene (70{\%})), CI-628 (α-[4-pyrrolidinoethoxy]-phenyl-4-methoxy-α'-nitrostilbene (5{\%})), 11α-methoxyethynylestradiol, RU16117 (11α-methoxy-17α-ethynylestra-1,3,5(10)-triene-3,17β-diol (4{\%})), tamoxifen (trans-1 (p-dimethylaminoethoxyphenyl)-1,2-diphenyl-1-butene (5{\%})), and U23,469 ((±)-cis-3-[p-(1,2,3,4-tetrahydro-6-methoxy-2-phenyl-1-naphthyl)phenoxy]-1,2-propanediol (0.3{\%})). Ligand-mediated thermal stability and resistance to tryptic proteolysis were observed to be closely related to binding affinity for receptor and not to whether the ligand was an agonist or antagonist. Consequently, while the receptor may distinguish an agonist from an antagonist by some resulting conformational perturbation that is ultimately translated into different biological responses, this change is not manifested in any characteristic fashion by ligand-mediated thermal stability or protection against tryptic proteolysis.",
author = "Pavlik, {E. J.} and Katzenellenbogen, {Benita S}",
year = "1980",
language = "English (US)",
volume = "18",
pages = "406--412",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "3",

}

TY - JOUR

T1 - The stability of the uterine estrogen receptor when complexed with estrogens or antiestrogens

AU - Pavlik, E. J.

AU - Katzenellenbogen, Benita S

PY - 1980

Y1 - 1980

N2 - As probes for possible conformational differences in estrogen receptor complexes when liganded with estrogen agonists or estrogen antagonists (antiestrogens), we have examined ligand-mediated thermal stability and resistance to trypsin-mediated proteolysis of uterine receptors occupied by a variety of steroidal and nonsteroidal estrogens and antiestrogens displaying a wide range of binding affinities for receptor. The estrogens examined (with chemical names and relative binding affinities in parentheses) were diethylstilbestrol (α,α'-diethyl-4,4'-stilbenediol (126%)), estradiol-17β (estra-1,3,5(10)-triene-3,17β-diol (100%)), 11β-methoxy-17-α-ethynylestradiol, R2858 (11β-methoxy-17α-ethynyl-estra-1,3,5(10)triene-3,17β-diol (65%)), zearalanol, P-1496 (6-(6,10-dihydroxyundecyl)-β-resorcylic acid μ-lactone (14%)), estriol (estra-1,3,5(10)-triene-3,16α,17β-triol (19%)), estrone (3-hydroxy-estra-1,3,5(10)-triene-17-one (15%)), and estradiol-17α (estra-1,3,5(10)-triene-3,17α-diol (5%)); the antiestrogens examined were CI-628 demethylated (α-[4-pyrrolidinoethoxy]phenyl4-hydroxy-α'-nitrostilbene (70%)), CI-628 (α-[4-pyrrolidinoethoxy]-phenyl-4-methoxy-α'-nitrostilbene (5%)), 11α-methoxyethynylestradiol, RU16117 (11α-methoxy-17α-ethynylestra-1,3,5(10)-triene-3,17β-diol (4%)), tamoxifen (trans-1 (p-dimethylaminoethoxyphenyl)-1,2-diphenyl-1-butene (5%)), and U23,469 ((±)-cis-3-[p-(1,2,3,4-tetrahydro-6-methoxy-2-phenyl-1-naphthyl)phenoxy]-1,2-propanediol (0.3%)). Ligand-mediated thermal stability and resistance to tryptic proteolysis were observed to be closely related to binding affinity for receptor and not to whether the ligand was an agonist or antagonist. Consequently, while the receptor may distinguish an agonist from an antagonist by some resulting conformational perturbation that is ultimately translated into different biological responses, this change is not manifested in any characteristic fashion by ligand-mediated thermal stability or protection against tryptic proteolysis.

AB - As probes for possible conformational differences in estrogen receptor complexes when liganded with estrogen agonists or estrogen antagonists (antiestrogens), we have examined ligand-mediated thermal stability and resistance to trypsin-mediated proteolysis of uterine receptors occupied by a variety of steroidal and nonsteroidal estrogens and antiestrogens displaying a wide range of binding affinities for receptor. The estrogens examined (with chemical names and relative binding affinities in parentheses) were diethylstilbestrol (α,α'-diethyl-4,4'-stilbenediol (126%)), estradiol-17β (estra-1,3,5(10)-triene-3,17β-diol (100%)), 11β-methoxy-17-α-ethynylestradiol, R2858 (11β-methoxy-17α-ethynyl-estra-1,3,5(10)triene-3,17β-diol (65%)), zearalanol, P-1496 (6-(6,10-dihydroxyundecyl)-β-resorcylic acid μ-lactone (14%)), estriol (estra-1,3,5(10)-triene-3,16α,17β-triol (19%)), estrone (3-hydroxy-estra-1,3,5(10)-triene-17-one (15%)), and estradiol-17α (estra-1,3,5(10)-triene-3,17α-diol (5%)); the antiestrogens examined were CI-628 demethylated (α-[4-pyrrolidinoethoxy]phenyl4-hydroxy-α'-nitrostilbene (70%)), CI-628 (α-[4-pyrrolidinoethoxy]-phenyl-4-methoxy-α'-nitrostilbene (5%)), 11α-methoxyethynylestradiol, RU16117 (11α-methoxy-17α-ethynylestra-1,3,5(10)-triene-3,17β-diol (4%)), tamoxifen (trans-1 (p-dimethylaminoethoxyphenyl)-1,2-diphenyl-1-butene (5%)), and U23,469 ((±)-cis-3-[p-(1,2,3,4-tetrahydro-6-methoxy-2-phenyl-1-naphthyl)phenoxy]-1,2-propanediol (0.3%)). Ligand-mediated thermal stability and resistance to tryptic proteolysis were observed to be closely related to binding affinity for receptor and not to whether the ligand was an agonist or antagonist. Consequently, while the receptor may distinguish an agonist from an antagonist by some resulting conformational perturbation that is ultimately translated into different biological responses, this change is not manifested in any characteristic fashion by ligand-mediated thermal stability or protection against tryptic proteolysis.

UR - http://www.scopus.com/inward/record.url?scp=0019174281&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019174281&partnerID=8YFLogxK

M3 - Article

C2 - 7464805

AN - SCOPUS:0019174281

VL - 18

SP - 406

EP - 412

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 3

ER -